Volume 7, Issue 1, July 2014, Pages 376–381
W. Dorisa Jenifer1, M.S. Gincy2, and S. P.G. Indu3
1 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
2 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
3 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Production of biosimilars, similar to the original pharmaceuticals that faces certain challenges like possible need for unique naming to differentiate the various biopharmaceutical products, regulatory framework and commercial opportunities have made the researchers in head over heels to design the appropriate one. Clinical applications have to be the main target that relies on cost-effectiveness and market value.
Author Keywords: biosimilars, biopharmaceutical products, clinical applications, market value.
W. Dorisa Jenifer1, M.S. Gincy2, and S. P.G. Indu3
1 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
2 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
3 Department of Biotechnology, Udaya School of Engineering, Udaya Nagar, Vellamoodi, Kanyakumari Dist-629204, India
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Production of biosimilars, similar to the original pharmaceuticals that faces certain challenges like possible need for unique naming to differentiate the various biopharmaceutical products, regulatory framework and commercial opportunities have made the researchers in head over heels to design the appropriate one. Clinical applications have to be the main target that relies on cost-effectiveness and market value.
Author Keywords: biosimilars, biopharmaceutical products, clinical applications, market value.
How to Cite this Article
W. Dorisa Jenifer, M.S. Gincy, and S. P.G. Indu, “An Analysis on Biosimilars,” International Journal of Innovation and Applied Studies, vol. 7, no. 1, pp. 376–381, July 2014.
